View in EDS

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.

Saved in:
Bibliographic Details
Title: Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.
Authors: Tzellos, Thrasyvoulos1,2 (AUTHOR) thrasyvoulos.tzellos@nordlandssykehuset.no, Giamarellos‐Bourboulis, Evangelos J.1,3 (AUTHOR), Straalen, Kelsey R.4 (AUTHOR), Martorell, Antonio1,5 (AUTHOR), Kirby, Brian1,6 (AUTHOR), Alavi, Afsaneh1,7 (AUTHOR), Hayama, Koremasa8 (AUTHOR), Khattri, Saakshi9 (AUTHOR), Gulliver, Wayne10 (AUTHOR), Sayed, Christopher J.1,11 (AUTHOR), Davis, Leah12 (AUTHOR), Rolleri, Robert L.12 (AUTHOR), Crater, Christina12 (AUTHOR), Pansar, Ingrid12 (AUTHOR), Lambert, Jérémy12 (AUTHOR), Zouboulis, Christos C.1,13,14,15,16 (AUTHOR)
Source: Journal of the European Academy of Dermatology & Venereology. Feb2026, p1. 10p. 5 Illustrations.
Database: Academic Search Ultimate
Description
ISSN:09269959
DOI:10.1111/jdv.70356